Clinical Trials for BlueSky Immunotherapies

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: BlueSky Immunotherapies

Clinical Trials (2)

NCT06589609
Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer
PHASE1Recruiting
12 participants
Started: Aug 23, 2024 · Completed: Nov 30, 2029
1 condition1 sponsor1 location
NCT05829629
Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women
PHASE1Recruiting
20 participants
Started: Sep 12, 2023 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location